| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,956 |
18,572 |
$1.82M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,077 |
14,341 |
$1.76M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,242 |
3,185 |
$359K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,781 |
6,728 |
$349K |
| 99442 |
|
3,205 |
2,913 |
$340K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,622 |
2,423 |
$274K |
| 90461 |
|
3,739 |
3,721 |
$247K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,740 |
4,517 |
$243K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,314 |
2,307 |
$239K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,610 |
5,515 |
$213K |
| 99215 |
Prolong outpt/office vis |
828 |
755 |
$152K |
| 99177 |
|
4,894 |
4,877 |
$141K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,238 |
1,237 |
$128K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,428 |
2,273 |
$110K |
| 87634 |
|
1,202 |
1,170 |
$84K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,994 |
5,649 |
$82K |
| 99173 |
|
2,606 |
2,594 |
$72K |
| 88738 |
|
13,101 |
9,383 |
$66K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
584 |
583 |
$61K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,105 |
1,092 |
$58K |
| 99422 |
|
763 |
699 |
$46K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
418 |
417 |
$42K |
| 90791 |
Psychiatric diagnostic evaluation |
153 |
152 |
$40K |
| 83655 |
|
2,924 |
2,914 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,995 |
1,459 |
$38K |
| Q3014 |
Telehealth originating site facility fee |
1,336 |
1,185 |
$38K |
| 90837 |
Psychotherapy, 53 minutes with patient |
226 |
138 |
$36K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,305 |
1,204 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,896 |
1,777 |
$30K |
| 86328 |
|
628 |
607 |
$29K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
195 |
195 |
$29K |
| 82962 |
|
8,113 |
8,035 |
$28K |
| 85018 |
|
9,047 |
8,956 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
738 |
703 |
$22K |
| 80305 |
|
1,303 |
1,253 |
$17K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
681 |
661 |
$16K |
| 92551 |
|
1,410 |
1,408 |
$16K |
| S9999 |
Sales tax |
1,631 |
1,059 |
$15K |
| 87631 |
|
82 |
81 |
$14K |
| 99050 |
|
1,226 |
975 |
$14K |
| 81003 |
|
6,628 |
6,224 |
$13K |
| 90686 |
|
1,837 |
1,831 |
$13K |
| 99443 |
|
92 |
90 |
$12K |
| 99080 |
|
1,770 |
1,384 |
$12K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
55 |
46 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,572 |
2,365 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
977 |
975 |
$10K |
| 86769 |
|
209 |
198 |
$9K |
| 99205 |
Prolong outpt/office vis |
41 |
41 |
$9K |
| 99441 |
|
176 |
169 |
$9K |
| 80061 |
Lipid panel |
635 |
632 |
$8K |
| 90834 |
Psychotherapy, 45 minutes with patient |
44 |
40 |
$4K |
| 87807 |
|
291 |
274 |
$4K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
15 |
14 |
$4K |
| H0033 |
Oral medication administration, direct observation |
101 |
101 |
$3K |
| 99382 |
|
14 |
14 |
$2K |
| 99381 |
|
13 |
13 |
$2K |
| 99072 |
|
4,516 |
3,421 |
$2K |
| 90670 |
|
1,120 |
1,115 |
$1K |
| 81001 |
|
389 |
378 |
$1K |
| 94760 |
|
3,772 |
3,087 |
$1K |
| 90473 |
|
64 |
64 |
$929.49 |
| 92552 |
|
49 |
49 |
$838.25 |
| 92567 |
|
38 |
38 |
$534.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
350 |
304 |
$502.89 |
| 36416 |
|
2,234 |
1,605 |
$460.66 |
| 90651 |
|
290 |
290 |
$383.10 |
| 90656 |
|
74 |
74 |
$324.40 |
| 99188 |
|
41 |
41 |
$320.00 |
| 90734 |
|
134 |
134 |
$275.28 |
| 90681 |
|
380 |
379 |
$266.66 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
25 |
$259.45 |
| 90688 |
|
14 |
14 |
$210.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
327 |
325 |
$163.52 |
| 90647 |
|
1,110 |
1,106 |
$135.27 |
| 81025 |
|
14 |
14 |
$118.39 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
60 |
56 |
$86.51 |
| 90723 |
|
454 |
453 |
$63.72 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
31 |
29 |
$62.56 |
| 90633 |
|
603 |
600 |
$37.17 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12 |
12 |
$1.05 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,089 |
839 |
$0.00 |
| 3044F |
|
723 |
553 |
$0.00 |
| 90677 |
|
399 |
396 |
$0.00 |
| 1036F |
|
1,516 |
1,045 |
$0.00 |
| A9150 |
Non-prescription drugs |
51 |
51 |
$0.00 |
| 90696 |
|
30 |
29 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
95 |
91 |
$0.00 |
| 90698 |
|
34 |
34 |
$0.00 |
| 90620 |
|
37 |
37 |
$0.00 |
| E0570 |
Nebulizer, with compressor |
14 |
14 |
$0.00 |
| 90716 |
|
24 |
24 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,097 |
838 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,604 |
1,107 |
$0.00 |
| 90710 |
|
330 |
328 |
$0.00 |
| 90671 |
|
203 |
203 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
253 |
183 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
108 |
102 |
$0.00 |
| D0415 |
|
18 |
18 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 90707 |
|
12 |
12 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
12 |
12 |
$0.00 |